SEC Form 4 · accession 0000899140-26-000947
Veradermics, Inc · MANE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Aug 19, 2026
Accepted (ET)
Aug 21, 2026 · 6:11 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001827635
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.00001 per shareF2,F1 | Aug 19, 2026 | S | 690,601 | $107.25 | D | 2,957,937 | I | See footnotes |
| Common stock, par value $0.00001 per shareF3,F1 | Aug 19, 2026 | S | 59,399 | $107.25 | D | 461,033 | I | See footnotes |
| Common stock, par value $0.00001 per shareF4,F6,F1 | Aug 20, 2026 | X | 149,000 | — | A | 3,106,937 | I | See footnotes |
| Common stock, par value $0.00001 per shareF5,F6,F1 | Aug 20, 2026 | X | 151,000 | — | A | 612,033 | I | See footnotes |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pre-Funded WarrantsF4,F1,F6,F7,F8 | — | Aug 20, 2026 | X | 149,000 | D | — | — | Common Stock | 149,000 | 0 | I |
| Pre-Funded WarrantsF5,F1,F6,F7,F8 | — | Aug 20, 2026 | X | 151,000 | D | — | — | Common Stock | 151,000 | 0 | I |
Explanation of responses
- F1Notes are included on Exhibit 99.1.
- F2Notes are included on Exhibit 99.1.
- F3Notes are included on Exhibit 99.1.
- F4Notes are included on Exhibit 99.1.
- F5Notes are included on Exhibit 99.1.
- F6Notes are included on Exhibit 99.1.
- F7Notes are included on Exhibit 99.1.
- F8Notes are included on Exhibit 99.1.
Remarks
Exhibit List: Exhibit 99.1 - Explanation of Responses Exhibit 99.2 - Joint Filer Information Exhibit 99.3 - Joint Filers' Signature